仟源医药：股东翁占国拟减持不超3%公司股份

Core Viewpoint - The major shareholder of QianYuan Pharmaceutical, Weng Zhangguo, plans to reduce his stake in the company by up to 7.6831 million shares, representing no more than 3% of the total share capital, due to personal financial needs [1] Summary by Category - Shareholder Action - Weng Zhangguo, holding more than 5% of the shares, intends to sell shares within a specified period from November 13, 2025, to February 12, 2026 [1] - The reduction will occur through centralized bidding and block trading methods [1] - Share Reduction Details - The maximum number of shares to be sold is 7.6831 million [1] - This sale will not exceed 3% of the company's total share capital [1]